Bleakley Financial Group’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69M Buy
31,747
+3,973
+14% +$320K 0.03% 400
2026
Q1
$1.96M Sell
27,774
-1,913
-6% -$143K 0.03% 389
2025
Q4
$2.34M Buy
29,687
+141
+0.5% +$11.2K 0.04% 322
2025
Q3
$2.43M Sell
29,546
-823
-3% -$64.8K 0.06% 265
2025
Q2
$2.44M Buy
30,369
+291
+1% +$22.5K 0.06% 254
2025
Q1
$2.41M Sell
30,078
-143
-0.5% -$11.9K 0.08% 214
2024
Q4
$2.47M Buy
30,221
+595
+2% +$49.5K 0.07% 220
2024
Q3
$2.44M Sell
29,626
-468
-2% -$35K 0.07% 214
2024
Q2
$2.11M Buy
30,094
+356
+1% +$25.4K 0.06% 273
2024
Q1
$2.2M Buy
29,738
+2,635
+10% +$184K 0.06% 279
2023
Q4
$1.79M Buy
27,103
+1,273
+5% +$79.7K 0.06% 293
2023
Q3
$1.62M Buy
25,830
+1,055
+4% +$65.7K 0.06% 294
2023
Q2
$1.4M Sell
24,775
-1,478
-6% -$82K 0.04% 333
2023
Q1
$1.52M Sell
26,253
-432
-2% -$29.2K 0.05% 310
2022
Q4
$1.93M Buy
+26,685
New +$1.91M 0.07% 253

Other funds holding MET

Bleakley Financial Group's MET Position: Q2 2026 in Review

Bleakley Financial Group increased its MetLife (MET) stake by 14% in Q2 2026, buying an estimated $320K and bringing the position to 31,747 shares worth $2.69M. The position accounts for 0.03% of the portfolio, ranked #400.

Bleakley Financial Group first reported a position in MET in Q4 2022 and has held it in 15 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Bleakley Financial Group held 31,747 shares of MetLife worth $2.69M as of Q2 2026.
  • Bleakley Financial Group bought 3,973 MetLife shares in Q2 2026, an estimated $320K.
  • MetLife made up 0.03% of Bleakley Financial Group's portfolio in Q2 2026, its #400 holding.
  • Bleakley Financial Group first reported a position in MetLife in Q4 2022 and has held it in 15 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.